Joel Isai Alcala-Gonzalez

Joel Isai Alcala-Gonzalez

Auto-generated profile, based on publicly available information

Joel Isai Alcala-Gonzalez

University Hospital “Dr. José Eleuterio González”, Autonomous University of Nuevo Leon

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Case Reports in Infectious Diseases
Verified
Journal Article
Open access
JAJoel Isai Alcala-Gonzalez
Joel Isai Alcala-Gonzalez
RLReynaldo Lara-Medrano
Reynaldo Lara-Medrano
KCKarla Paola Cuellar-Calderon
Karla Paola Cuellar-Calderon
ACAdrián Camacho-Ortiz
Adrián Camacho-Ortiz
Staphylococcus caprae , a non‐ aureus staphylococcus primarily associated with goats, is typically regarded as a commensal organism. While its role in veterinary contexts is well established, its emergence as a human pathogen in healthcare settings has gained increasing recognition. It has been implicated in infections such as bacteremia, otitis externa, osteoarticular infections, and prosthetic device–related complications. However, infective endocarditis caused by S. caprae remains extremely rare, with only six cases reported in the literature since 1995. This report presents a case of native valve infective endocarditis due to methicillin‐resistant S. caprae in a previously healthy 40‐year‐old male with no history of animal contact. The patient presented with fever, dyspnea, and signs of heart failure. Echocardiographic evaluation revealed vegetations on both the aortic and mitral valves, and blood cultures confirmed the presence of S. caprae . Initial empirical therapy with ceftriaxone and vancomycin was started and later adjusted to linezolid based on antimicrobial susceptibility testing. Despite appropriate antimicrobial treatment and intensive supportive care, the patient’s condition progressively deteriorated. He experienced neurological decline, hemodynamic instability, and ultimately died following cardiac arrest before surgical intervention could be performed. This case highlights the diagnostic challenges in identifying S. caprae , as conventional phenotypic methods often misclassify the organism. Advanced techniques such as MALDI‐TOF MS provide more accurate identification. Antimicrobial susceptibility testing is essential, as treatment options may vary. Fosfomycin resistance may serve as a presumptive marker for S. caprae , though cross‐resistance with other species limits its specificity. Given the rarity of S. caprae endocarditis, clinicians should maintain awareness of its potential occurrence, even in patients without animal exposure but with healthcare‐associated risks. Early microbiological diagnosis, targeted antibiotic therapy, and prompt surgical evaluation are crucial for managing this uncommon and clinically significant infection.

13 June 2026 in Future Microbiology
Verified
Journal Article
Closed access
MPMANUEL PAZ
MANUEL PAZ
KCKarla Paola Cuellar-Calderón
Karla Paola Cuellar-Calderón
SFSamantha Flores-Treviño
Samantha Flores-Treviño
JAJoel Isaí Alcala-González
Joel Isaí Alcala-González
MRMaría Teresa Ramírez-Elizondo
María Teresa Ramírez-Elizondo
ACAdrián Camacho-Ortiz
Adrián Camacho-Ortiz
Mycobacterium colombiense is a seldom reported non-tuberculous mycobacteria causing infections mostly in immunosuppressed patients. Thus, we present the findings of three M. colombiense isolation cases from a third-level hospital in Monterrey, Mexico, during 2020-2024. Mycobacterial identification was performed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and Anyplex™ MTB/NTM Real-time Detection. Patients were people living with Human Immunodeficiency Virus (PLHIV), with pneumonia and lymphadenopathy. Patients had high HIV viral loads and low CD4 counts (21-103 cells/mm3). None of the cases had specific Mycobacterium avium complex (MAC) treatment, and all of them showed clinical improvement. Current non-tuberculous mycobacteria discrimination tests may not effectively diagnose significant pathogens like M. colombiense, potentially leading to delays in treatment and negatively impacting patient outcomes.